PetMed Express (NASDAQ: PETS) director forfeits 26,057 shares on exit

Rhea-AI Filing Summary

PetMed Express director Gian Fulgoni reported an automatic forfeiture of 26,057 shares of common stock on January 21, 2026. The Form 4 shows this as a disposition at a price of $0.00 per share, reflecting that the shares were forfeited rather than sold for cash.

According to the footnote, the forfeiture was required under the applicable award agreement for restricted shares that had been granted on October 30, 2025, and occurred due to the termination of his director service as of January 21, 2026. After this change, Fulgoni directly beneficially owns 132,299 shares of PetMed Express common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FULGONI GIAN

(Last) (First) (Middle)

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FL 33445

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/21/2026		D		26,057(1)	D	$0	132,299	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 4 is being filed to reflect the automatic forfeiture, in accordance with the applicable award agreement, of a portion of the restricted shares granted on October 30, 2025 to the reporting person due to the termination of director service by the reporting person as of January 21, 2026.

Remarks:

	/s/ GIAN FULGONI	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PETS director Gian Fulgoni report?

Director Gian Fulgoni reported an automatic forfeiture of 26,057 shares of PetMed Express common stock on January 21, 2026, recorded as a disposition at $0.00 per share.

Why were 26,057 PetMed Express (PETS) shares forfeited by the director?

The footnote explains that the 26,057 shares were automatically forfeited under the applicable restricted share award agreement due to the termination of director service by Gian Fulgoni as of January 21, 2026.

Did the PetMed Express director receive any cash from this Form 4 transaction?

No. The transaction is reported at a price of $0.00 per share, indicating an automatic forfeiture of restricted shares rather than a sale for cash.

How many PetMed Express (PETS) shares does Gian Fulgoni own after the forfeiture?

After the reported forfeiture, Gian Fulgoni directly and beneficially owns 132,299 shares of PetMed Express common stock.

What was the origin of the forfeited PetMed Express restricted shares?

The forfeited shares were part of restricted shares granted on October 30, 2025 to Gian Fulgoni, which were subject to forfeiture under the terms of the award agreement upon termination of director service.

Is this PetMed Express Form 4 transaction a sale on the open market?

No. The Form 4 describes the event as an automatic forfeiture of restricted shares at $0.00 per share, not as an open-market sale.